Survey Data: Urology Education Needs
LUGPA and Medlive surveyed U.S. Urologists asking which topics they need education on, which formats they prefer, and which sources they trust.
Here’s what we found…
WHAT THEY WANT TO LEARN
What education topics do urologists want most?
Q: How interested would you be in learning more about the following topics?
% of urologists “very interested” in each topic
- Emerging and novel therapies 80%
- Diagnostic and imaging advances 80%
- Biomarker and genomic testing 61%
- Referral pathways and care coordination 35%
- Real-world case studies 31%
- Patient and caregiver communication 27%
Key insight
Anchor Programs in the Top Tier
4 out of 5 urologists were very interested in emerging and novel therapies or advances in diagnostic and imaging tools for urologic malignancies. Biomarker and genomic testing followed at 61%. Interest fell sharply for referral pathways and care coordination (35%), real-world case studies (31%), and patient and caregiver communication (27%). Pharma commercial and medical affairs teams reach more urologists by building those lower-interest topics into a program anchored on therapies, imaging, or biomarker testing rather than producing them as standalone modules.
IN THEIR OWN WORDS
Themes from open-ended responses
Q: What important clinical, practice, or professional topic should LUGPA provide education on that we have not addressed in this survey?
- 31%Billing, coding, and practice finances
- 24%New drug approvals and oncology advances
- 17%AI in practice
- 14%Patient communication and quality of life
Newer Mechanisms, Lower Confidence
The Emerging Therapies Urologists Feel Least Confident Discussing with Patients
Q: Which categories of therapies for urologic conditions are you least confident discussing with patients and caregivers?
- Gene- and cell-based therapies 67%
- Antibody-drug conjugates 55%
0%70%
Key insight
Brief Both Specialties
Gene- and cell-based therapies (67%) and antibody-drug conjugates (55%) are the categories urologists say they are least confident discussing with patients and caregivers, and both are now used at points in the disease where urology and oncology share the same patient. Teams launching in these categories should fund product-free, category-level education 6 to 9 months ahead of launch that covers the handoff between the two specialties, so the patient hears one consistent explanation of the therapy from both.
“Our Medlive Crossfire series is very helpful because it allows us to discuss the data…but what’s really important for community urologists is to understand how to take…these new concepts, and apply them to clinical practice. So what we like to focus on is not just the data, but how our practices are operationalizing that data, applying it to our patients.”
— Jason M. Hafron, MD, Chief Medical Officer and Medical Director of Clinical Research, Michigan Institute of Urology, an affiliate of Urology Alliance
WHO THEY TRUST
Why the Messenger Matters
- 88%of urologists trust their medical association or professional conferences for clinical information
- 67% trust their peers or KOLs for clinical information
AI AND UROLOGY PRACTICE
Where Urologists Want Help With AI
AI shows up three times in this survey without ever being the subject of a question. It is the second-most requested practice education topic, ahead of compensation models and practice finances, and five urologists raised it unprompted when asked what the survey had missed. The demand is operational rather than clinical: 1 in 3 want help implementing AI without naming it as a field they are struggling to keep up with.
- 71%flagged AI somewhere in the survey
- 59%want education on AI and technology implementation, second of 19 practice topics
- 37%say AI and digital health is changing fast enough to require ongoing education
TIME AND PLACE
Medlive Platform Engagement Insights
- 75.9% of learning sessions happen on desktop
- 10 AM is the peak engagement hour
- Tuesday is the busiest day of the week on the platform
Desktop v Mobile
- Desktop 75.9%
- Mobile 24.1%
Device share does vary by audience, as urologists are the second most likely to view educational content on a mobile device, behind rare oncologists, among the specialties we surveyed.
In response
Building Education that Aligns with Clinician’s Needs
Visit the programs below to see how LUGPA brings trusted urology education to clinicians through the Medlive platform.
Download Infographic
Fill out the form to receive your copy by email.
"*" indicates required fields